Home Industry Reports Custom Research Blogs About Us Contact us

Gastrointestinal Bleeding Treatment Market Size & Share, By Product (Endoscopic Hemostatic Devices [Mechanical, Thermal], Closure Devices), GI Tract Division (Upper, Lower), Onset (Acute, Chronic), End-use (Hospitals, ASCs), Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Report ID: FBI 2745


Published Date: May-2024


Format : PDF, Excel

Market Outlook:

Gastrointestinal Bleeding Treatment Market size exceeded USD 832.24 Million in 2023 and is likely to cross USD 1.68 Billion by end of the year 2032, observing around 8.2% CAGR between 2024 and 2032.

Base Year Value (2023)

USD 832.24 Million

19-23 x.x %
24-32 x.x %

CAGR (2024-2032)


19-23 x.x %
24-32 x.x %

Forecast Year Value (2032)

USD 1.68 Billion

19-23 x.x %
24-32 x.x %
Gastrointestinal Bleeding Treatment Market

Historical Data Period


Gastrointestinal Bleeding Treatment Market

Largest Region

North America

Gastrointestinal Bleeding Treatment Market

Forecast Period


Get more details on this report -

Market Dynamics:

Growth Drivers & Opportunity:

1. Increasing prevalence of gastrointestinal bleeding: The rising prevalence of gastrointestinal bleeding, attributed to factors such as aging population, unhealthy dietary habits, and increasing prevalence of chronic diseases such as cancer and ulcerative colitis, is a major driver for the growth of the gastrointestinal bleeding treatment market. The demand for effective and advanced treatment options for gastrointestinal bleeding is expected to increase significantly in the coming years.

2. Technological advancements in endoscopy and minimally invasive procedures: Technological advancements in endoscopy devices and minimally invasive procedures have significantly improved the diagnosis and treatment of gastrointestinal bleeding. These advancements have led to the development of more precise and targeted treatment options, thereby driving the demand for these products in the market.

3. Increasing healthcare expenditure and awareness: With the increasing healthcare expenditure and growing awareness about gastrointestinal disorders, there is a growing demand for effective treatment options for gastrointestinal bleeding. Patients are increasingly seeking advanced and minimally invasive treatment options, which is expected to drive the growth of the market.

4. Strategic collaborations and partnerships: Collaboration and partnerships between pharmaceutical companies, medical device manufacturers, and research organizations have led to the development of innovative treatment options for gastrointestinal bleeding. These collaborations are expected to drive the growth of the market by bringing new and advanced products to the market.

Report Scope

Report CoverageDetails
Segments CoveredProduct, Gi Tract Division, Onset, End-Use
Regions Covered• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company ProfiledBoston Scientific, CONMED, Cook Group, ERBE Elektromedizin, Medtronic PLC, Olympus, Ovesco Endoscopy AG, Pfizer, STERIS PLC, US Medical Innovations

Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!

Industry Restraints:

1. High cost of treatment: The high cost associated with advanced treatment options for gastrointestinal bleeding, including endoscopic procedures and minimally invasive surgeries, is a major restraint for market growth. The cost of these procedures can be prohibitive for patients, especially in developing countries, which can limit the adoption of these treatment options.

2. Stringent regulatory requirements: Stringent regulatory requirements for the approval of gastrointestinal bleeding treatment products can significantly impact the market growth. The lengthy and complex regulatory processes can delay the introduction of new products to the market, thereby limiting the growth potential of the market.

3. Limited reimbursement policies: Limited reimbursement policies for gastrointestinal bleeding treatment procedures in certain regions can act as a significant restraint for market growth. The lack of adequate reimbursement for these procedures can hinder the adoption of advanced treatment options by patients and healthcare providers, thus limiting market growth potential.

Regional Forecast:

Gastrointestinal Bleeding Treatment Market

Largest Region

North America

40% Market Share in 2023

Get more details on this report -

North America:

The gastrointestinal bleeding treatment market in North America is expected to witness significant growth, driven by the increasing prevalence of gastrointestinal disorders such as peptic ulcers, inflammatory bowel disease, and colorectal cancer. The United States and Canada are the key contributors to the market in this region, owing to the high incidence of gastrointestinal bleeding and the presence of well-established healthcare infrastructure.

Asia Pacific:

In Asia Pacific, countries such as China, Japan, and South Korea are anticipated to experience rapid growth in the gastrointestinal bleeding treatment market. The increasing aging population, changing dietary habits, and rising awareness about gastrointestinal disorders are some of the key factors driving market growth in this region. Additionally, the growing healthcare expenditure and advancements in medical technology are further expected to propel market growth in Asia Pacific.


The gastrointestinal bleeding treatment market in Europe is poised for significant expansion, with countries like the United Kingdom, Germany, and France at the forefront of market growth. The increasing prevalence of gastrointestinal diseases, favorable reimbursement policies, and the presence of well-established healthcare infrastructure are driving the market in this region. Additionally, the rising adoption of advanced treatment methods and the availability of skilled healthcare professionals are further contributing to market growth in Europe.

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
Gastrointestinal Bleeding Treatment Market
Gastrointestinal Bleeding Treatment Market

Segmentation Analysis:


In terms of segmentation, the global gastrointestinal bleeding treatment market is analyzed on the basis of Product, Gi Tract Division, Onset, End-Use.

Gastrointestinal Bleeding Treatment Market


The product segment in the gastrointestinal bleeding treatment market refers to the various types of medications and medical devices used to treat gastrointestinal bleeding. This includes pharmaceutical drugs such as proton pump inhibitors, antacids, and H2-receptor antagonists, as well as endoscopic devices such as hemostatic clips and thermal coagulation devices. The product segment is a key factor in driving the growth of the gastrointestinal bleeding treatment market, as advancements in treatment options and the availability of new products continue to drive market expansion.

Gi Tract Division

The GI tract division segment in the gastrointestinal bleeding treatment market refers to the different parts of the gastrointestinal system that can be affected by bleeding. This includes the esophagus, stomach, small intestine, large intestine, and rectum. Gastrointestinal bleeding can occur in any of these divisions, and the treatment approach may vary depending on the location and severity of the bleeding. Understanding the GI tract division segment is important for market analysis, as it allows for a deeper understanding of the specific needs and trends within each segment of the gastrointestinal bleeding treatment market.


The onset segment in the gastrointestinal bleeding treatment market refers to the timing of the bleeding, including acute and chronic bleeding. Acute gastrointestinal bleeding is characterized by a sudden and severe onset of bleeding, often requiring immediate medical intervention. Chronic gastrointestinal bleeding, on the other hand, is characterized by long-term or recurring bleeding episodes, which may require ongoing treatment and management. The onset segment is a crucial aspect of market analysis, as it provides insights into the demand for different treatment options based on the timing of the bleeding.


The end-use segment in the gastrointestinal bleeding treatment market refers to the different healthcare settings where gastrointestinal bleeding treatment products are used. This includes hospitals, ambulatory surgical centers, and specialty clinics. The end-use segment is important for understanding the distribution and utilization of gastrointestinal bleeding treatment products, as well as the market dynamics within each healthcare setting. This segment also plays a role in market forecasting and evaluating the potential for market growth based on the demand for gastrointestinal bleeding treatment products in different end-use settings.

Get more details on this report -

Competitive Landscape:

The competitive landscape in the Gastrointestinal Bleeding Treatment Market is characterized by a number of key players vying for market share through product innovation, strategic partnerships, and acquisitions. With the increasing prevalence of gastrointestinal bleeding disorders and the demand for effective treatment options, the market is witnessing intense competition. The top players in the market are focusing on expanding their product portfolio, geographic reach, and research and development efforts to gain a competitive edge. Additionally, the market is also witnessing the entry of new players with innovative treatment options, further intensifying the competition.

Top Market Players:

1. Boston Scientific Corporation

2. Cook Medical

3. Olympus Corporation

4. CONMED Corporation

5. Fujifilm Holdings Corporation

6. Medtronic plc

7. ERBE Elektromedizin GmbH

8. Teleflex Incorporated

9. Wilson-Cook Medical Inc.

10. Stryker Corporation

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Gastrointestinal Bleeding Treatment Market Size & ...

RD Code : 24